AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 142 filers reported holding AMICUS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | -95.7% | 22,500 | -74.3% | 0.00% | -100.0% |
| Q1 2019 | $47,000 | -60.2% | 87,500 | +608.3% | 0.01% | -61.5% |
| Q4 2018 | $118,000 | +53.2% | 12,353 | -42.5% | 0.01% | +85.7% |
| Q3 2018 | $77,000 | -96.9% | 21,500 | -86.4% | 0.01% | -93.3% |
| Q2 2018 | $2,471,000 | +11.5% | 158,200 | +7.6% | 0.10% | +34.6% |
| Q3 2017 | $2,217,000 | +219.5% | 147,000 | +113.0% | 0.08% | +105.3% |
| Q2 2017 | $694,000 | +73.5% | 69,000 | +223.2% | 0.04% | +100.0% |
| Q1 2017 | $400,000 | +52.7% | 21,350 | -31.1% | 0.02% | +90.0% |
| Q1 2016 | $262,000 | +74.7% | 31,000 | +100.0% | 0.01% | -9.1% |
| Q4 2015 | $150,000 | – | 15,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |